Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer. Yesterday, May 21, 2015, 117 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $233.20 to $1,180,446,250.00.
Highlighted Stocks Traded by Insiders:
Collectors Universe (CLCT) - FREE Research Report Hall David G, who is President at Collectors Universe, sold 20,000 shares at $22.84 on May 21, 2015. Following this transaction, the President owned 639,999 shares meaning that the stake was reduced by 3.03% with the 20,000-share transaction.
The shares most recently traded at $21.40, down $1.44, or 6.73% since the insider transaction. Historical insider transactions for Collectors Universe go as follows:
- 4-Week # shares bought: 10,000
- 4-Week # shares sold: 40,000
- 12-Week # shares bought: 10,000
- 12-Week # shares sold: 64,801
- 24-Week # shares bought: 10,000
- 24-Week # shares sold: 109,793
The average volume for Collectors Universe has been 23,600 shares per day over the past 30 days. Collectors Universe has a market cap of $195.9 million and is part of the services sector and diversified services industry. Shares are up 4.46% year-to-date as of the close of trading on Thursday.
Collectors Universe Inc. provides third-party authentication, grading, and related services for rare and high-value collectibles consisting of coins, trading cards, sports memorabilia, and autographs. The stock currently has a dividend yield of 6.35%. The company has a P/E ratio of 23.2. Currently, there are no analysts who rate Collectors Universe a buy, no analysts rate it a sell, and none rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on CLCT - FREE TheStreet Quant Ratings rates Collectors Universe as a
buy. The company's strengths can be seen in multiple areas, such as its increase in net income, largely solid financial position with reasonable debt levels by most measures, notable return on equity, expanding profit margins and increase in stock price during the past year. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full
Collectors Universe Ratings Report from
TheStreet Quant Ratings now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
One Horizon Group (OHGI) - FREE Research Report White Mark Brian, who is 10% Owner at One Horizon Group, sold 169,500 shares at $2.08 on May 21, 2015. Following this transaction, the 10% Owner owned 5.4 million shares meaning that the stake was reduced by 3.04% with the 169,500-share transaction.
The shares most recently traded at $1.69, down $0.39, or 23.31% since the insider transaction. Historical insider transactions for One Horizon Group go as follows:
- 4-Week # shares sold: 159,500
- 12-Week # shares sold: 159,500
- 24-Week # shares sold: 403,500
The average volume for One Horizon Group has been 158,200 shares per day over the past 30 days. One Horizon Group has a market cap of $60.6 million and is part of the technology sector and computer software & services industry. Shares are down 11.06% year-to-date as of the close of trading on Thursday.
One Horizon Group, Inc., through its subsidiaries, develops and licenses software solutions to telecommunications operators in Europe, Asia, the Russian Federation, and the United States.
Exclusive Offer: Get the latest Stock Analysis on OHGI - FREE TheStreet Quant Ratings rates One Horizon Group as a
sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, disappointing return on equity, generally disappointing historical performance in the stock itself and feeble growth in its earnings per share. Get the full
One Horizon Group Ratings Report from
TheStreet Quant Ratings now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Endologix (ELGX) - FREE Research Report Lima Jose A., who is VP-Quality at Endologix, sold 1,872 shares at $16.75 on May 21, 2015. Following this transaction, the VP-Quality owned 12,012 shares meaning that the stake was reduced by 13.48% with the 1,872-share transaction.
The shares most recently traded at $16.51, down $0.24, or 1.45% since the insider transaction. Historical insider transactions for Endologix go as follows:
- 4-Week # shares bought: 2,000
- 4-Week # shares sold: 45,000
- 12-Week # shares bought: 2,000
- 12-Week # shares sold: 45,000
- 24-Week # shares bought: 2,000
- 24-Week # shares sold: 55,000
The average volume for Endologix has been 598,800 shares per day over the past 30 days. Endologix has a market cap of $1.1 billion and is part of the health care sector and health services industry. Shares are up 8.76% year-to-date as of the close of trading on Thursday.
Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally. Currently, there are 2 analysts who rate Endologix a buy, no analysts rate it a sell, and 2 rate it a hold.
Exclusive Offer: Get the latest Stock Analysis on ELGX - FREE TheStreet Quant Ratings rates Endologix as a
sell. The company's weaknesses can be seen in multiple areas, such as its feeble growth in its earnings per share, deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full
Endologix Ratings Report from
TheStreet Quant Ratings now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
